Regarding the constituents of our 7-gene signature, CACNA1C is overexpressed in high-grade serous ovarian cancer and correlated with prognosis [30], whereas COL16A1 expression is significantly correlated with progression-free survival in advanced serous ovarian cancer [31]. The gene discussed is COL16A1; the disease is ovarian serous adenocarcinoma.